DNA Hypomethylation is Not Cell Intrinsically Toxic to Polycomb Repressive Complex 2 Deficient Malignant Peripheral Nerve Sheath Tumors
DNA methylation · human · 36 samples
- What it is
- DNA methylationChemical marks on DNA that help switch genes on or off.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 36 samples: 18 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE305426_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for beta-value tables or raw IDAT files among the supplementary files.
Also filed as BioProject PRJNA1305719 and SRA study SRP608856. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 18 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9176989 JH-2-002-CL-AZA-1 JH-2-002-CL-AZA
- GSM9176990 JH-2-002-CL-AZA-2 JH-2-002-CL-AZA
- GSM9176991 JH-2-002-CL-DAC-1 JH-2-002-CL-DAC
- GSM9176992 JH-2-002-CL-DAC-2 JH-2-002-CL-DAC
- GSM9176993 JH-2-002-CL-DMSO-1 JH-2-002-CL-DMSO
- GSM9176994 JH-2-002-CL-DMSO-2 JH-2-002-CL-DMSO
- GSM9176995 ST88-14-AZA-1 ST88-14-AZA
- GSM9176996 ST88-14-AZA-2 ST88-14-AZA
- GSM9176997 ST88-14-DAC-1 ST88-14-DAC
- GSM9176998 ST88-14-DAC-2 ST88-14-DAC
- GSM9176999 ST88-14-DMSO-1 ST88-14-DMSO
- GSM9177000 ST88-14-DMSO-2 ST88-14-DMSO
- GSM9177001 STS26T-AZA-1 STS26T-AZA
- GSM9177002 STS26T-AZA-2 STS26T-AZA
- GSM9177003 STS26T-DAC-1 STS26T-DAC
- GSM9177004 STS26T-DAC-2 STS26T-DAC
- GSM9177005 STS26T-DMSO-1 STS26T-DMSO
- GSM9177006 STS26T-DMSO-2 STS26T-DMSO
- GSM9177007 TY-AZA-1 TY-AZA
- GSM9177008 TY-AZA-2 TY-AZA
- GSM9177009 TY-DAC-1 TY-DAC
- GSM9177010 TY-DAC-2 TY-DAC
- GSM9177011 TY-DMSO-1 TY-DMSO
- GSM9177012 TY-DMSO-2 TY-DMSO
- GSM9177013 TY-DMSO-AZA-1 TY-DMSO-AZA
- GSM9177014 TY-DMSO-AZA-2 TY-DMSO-AZA
- GSM9177015 TY-DMSO-DAC-1 TY-DMSO-DAC
- GSM9177016 TY-DMSO-DAC-2 TY-DMSO-DAC
- GSM9177017 TY-DMSO-DMSO-1 TY-DMSO-DMSO
- GSM9177018 TY-DMSO-DMSO-2 TY-DMSO-DMSO
- GSM9177019 TY-DOX-AZA-1 TY-DOX-AZA
- GSM9177020 TY-DOX-AZA-2 TY-DOX-AZA
- GSM9177021 TY-DOX-DAC-1 TY-DOX-DAC
- GSM9177022 TY-DOX-DAC-2 TY-DOX-DAC
- GSM9177023 TY-DOX-DMSO-1 TY-DOX-DMSO
- GSM9177024 TY-DOX-DMSO-2 TY-DOX-DMSO
- GSE312030 Combined inhibition of HRAS and MEK induces tumor regression and restores myogenic differentiation in HRAS-mutant rhabdomyosarcoma 159 samples same disease briefing
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples same disease briefing
- GSE300974 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [RNA-seq] 30 samples same disease briefing
- GSE314949 RNA Seq of rhabdomyosarcoma cells with sgRNA targeting oncofusion interacting proteins 30 samples same disease briefing
- GSE279954 mRNA/sRNA Co-Sequencing Reveals Multiple New Targeted Therapy Candidates in Rhabdomyosarcoma 26 samples same disease briefing
- GSE292872 FANCM is Required for the PAX3::FOXO1-Driven Oncogenic Program in Rhabdomyosarcoma [RNA-Seq] 21 samples same disease briefing
- GSE144190 Systematic profiling of synovial sarcoma transcriptome 20 samples same disease briefing
- GSE202614 TLE3 function in rhabdomyosarcoma tumor xenografts. 20 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.